scispace - formally typeset
M

Markus R. Wenk

Researcher at National University of Singapore

Publications -  332
Citations -  25285

Markus R. Wenk is an academic researcher from National University of Singapore. The author has contributed to research in topics: Medicine & Lipid metabolism. The author has an hindex of 81, co-authored 292 publications receiving 21516 citations. Previous affiliations of Markus R. Wenk include Swiss Tropical and Public Health Institute & University of Geneva.

Papers
More filters
Journal ArticleDOI

Meibum Lipid Composition in Asians with Dry Eye Disease

TL;DR: A comprehensive lipidome of meibum from individuals of an Asian ethnicity is presented, for the first time, which can potentially offer new insights into the higher prevalence of dysfunctional tear syndrome observed amongst Asian populations.
Journal ArticleDOI

Structural and biochemical characterization of the type III secretion chaperones CesT and SigE

TL;DR: Isothermal titration calorimetry studies of Tir–CesT and enzymatic activity profiles of SigD–SigE indicate that the effector proteins are not globally unfolded in the presence of their cognate chaperones, and variable, delocalized hydrophobic surfaces observed on the chaperone homodimers are responsible for specific binding to a particular effector protein.
Journal ArticleDOI

Lipid transport by TMEM24 at ER–plasma membrane contacts regulates pulsatile insulin secretion

TL;DR: A mechanism through which TMEM24, a lipid transport protein that concentrates at endoplasmic reticulum–plasma membrane contact sites, regulates the pulsatility of cytosolic Ca2+ and phosphoinositide signaling is reported, which regulates pulsatile insulin secretion during the slow insulin release phase.
Journal ArticleDOI

Lipid pathway alterations in Parkinson's Disease primary visual cortex

TL;DR: The data indicate that changes in lipid metabolism occur in the Parkinson's disease visual cortex in the absence of obvious pathology, which suggests that normalization of lipid metabolism and/or oxidative stress status in the visual cortex may represent a novel route for treatment of non-motor symptoms, such as visual hallucinations, that are experienced by a majority of Parkinson's patients.